A Cohort Study to Test That There is a Low Risk of Recurrent VTE in Patients With a First Episode of Unprovoked VTE Who Stop Anticoagulant Therapy After 3 Months of Treatment in Response to Negative D-dimer Testing
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 410
- 试验地点
- 13
- 主要终点
- Bleeding
研究概览
简要总结
The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negative D-dimer test on therapy and 1 month after stopping therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be >= 18 years of age
- •Have had ONE episode of unprovoked proximal DVT and/or PE
- •Have completed 3 uninterrupted months of warfarin therapy (target INR of 2.0-3.0)
排除标准
- •Another indication for long-term anticoagulation (e.g., atrial fibrillation)
- •A high risk of bleeding as evidenced by any of the following:
- •Age greater than 75 years
- •Previous episode of major bleeding where the cause was not effectively treated
- •Known chronic thrombocytopenia with a platelet count of less than 120,000 x 10^9 /L
- •Known chronic renal impairment with a creatinine of more than 150 mumols /litre (1.7 mg/dl)
- •Known chronic liver disease with a total bilirubin of more than 25 mumols /litre (1.5 mg/dl)
- •Active peptic ulcer disease
- •Poor compliance with, or control of, anticoagulant therapy during initial treatment
- •Requires dual antiplatelet therapy (e.g. aspirin and clopidogrel)
- •A vena caval filter
- •Has had D-dimer testing performed within 2 months of potential enrollment other than for evaluation of suspected recurrent VTE that was not confirmed
- •Has a life expectancy less than 5 years
- •Is unable to attend follow-up visits because of geographic inaccessibility
- •Is participating in a competing clinical investigation
研究组 & 干预措施
No Anticoagulant Therapy
No Anticoagulant Therapy
干预措施: Discontinue anticoagulant therapy (Negative d-dimer) (Other)
Anticoagulant Therapy
Continue on anticoagulant therapy
干预措施: Continue on anticoagulant therapy (positive d-dimer) (Other)
结局指标
主要结局
Bleeding
时间窗: up to 7 years
Suspected Recurrent DVT
时间窗: up to 7 years
Suspected (recurrent) pulmonary embolism
时间窗: up to 7 years
Death
时间窗: up to 7 years
次要结局
未报告次要终点
